Furthermore, the higher expression of CKS2 in cervical cancer patients with stage II from inhouse microarrays and the adverse impact of CKS2 overexpression on the disease-free survival conditions of cervical cancer patients in GSE44001 indicated the promotive effect of CKS2 overexpression in augmenting the malignancy of cervical cancer. The gene discussed is CKS2; the disease is cervical carcinoma.